(Bloomberg) The global push to use artificial intelligence to find new medicines faces a crucial test as one front-runner starts approaching late-stage trials for a drug discovered by algorithms. Most Read from BloombergWall Street Divided Over Just How Aggressive Fed Cutting Will BeUBS Strategists See Far Deeper Fed Rate Cuts Than What Markets Are PricingIsrael Latest: Yellen Sees Limited Global Economic Impact So FarChina Weighs Ending Freeze on Boeing With 737 Max Deal in USBiden, Xi to An
Race for First Drug Discovered by AI Nears Key Milestone bnnbloomberg.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bnnbloomberg.ca Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ The Japan regenerative medicine market size is expected to grow by USD 2.33 billion from 2022 to 2027. In addition, the momentum of the market.